The proton therapy market would grow at a CAGR of 17.29% over the predicted time frame. The market is expected to increase in value from US$ 530 Mn in 2022 to US$ 1.9 Bn in 2030.
The on proton therapy Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2337
A recent report provides crucial insights along with application based and forecast information in the Global Proton therapy Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Proton therapy market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Proton therapy market are included as given below:
Proton therapy Market Key Players
- IBA Worldwide
- Varian medical systems, Inc
- HItachi, Ltd
- Mevion medical systems
- Sumitomo Heavy Industries, Ltd
- Optivus Proton Therapy
- Advanced Oncotherapy plc
- ProTom International
- Mitsubishi Corporation
- ProNova Solutions LLC
- Sun Nuclear Corporation
- Provision Healthcare
- Koninklijke Philips N.V
- Elekta AB
- GE Healthcare
- Best Cyclotron Systems
- Ray Search Laboratories
- Permedics
Market Segments
By Indication
- Breast cancer
- Prostate cancer
- CNS cancer
- Head and Neck cancer
- Others
By Product
- Accelerator
- Beam transport system
- Bean delivery system
- Nozzle and image viewers
- Patient positioning system
By Type
- Rotating Proton Therapy Systems
- Non-Rotating Proton Therapy Systems
By Set-Up Systems
- Multi-Room Systems
- Compact/ Single-Room Systems
By Application Type
- Treatment Applications
- Research Applications
By End-User
- Hospitals
- Proton therapy center
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global proton therapy market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the proton therapy market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Proton Therapy Market
5.1. COVID-19 Landscape: Proton Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Proton Therapy Market, By Indication
8.1. Proton Therapy Market, by Indication, 2022-2030
8.1.1. Breast cancer
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Prostate cancer
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. CNS cancer
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Head and Neck cancer
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Proton Therapy Market, By Product
9.1. Proton Therapy Market, by Product, 2022-2030
9.1.1. Tence
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Beam transport system
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Bean delivery system
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Nozzle and image viewers
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Patient positioning system
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Proton Therapy Market, By Type
10.1. Proton Therapy Market, by Type, 2022-2030
10.1.1. Rotating Proton Therapy Systems
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Non-Rotating Proton Therapy Systems
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Proton Therapy Market, By Set-Up Systems
11.1. Proton Therapy Market, by Set-Up Systems, 2022-2030
11.1.1. Multi-Room Systems
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Compact/ Single-Room Systems
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Proton Therapy Market, By Application Type
12.1. Proton Therapy Market, by Application Type, 2022-2030
12.1.1. Treatment Applications
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Research Applications
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Proton Therapy Market, By End-User
13.1. Proton Therapy Market, by End-User, 2022-2030
13.1.1. Hospitals
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Proton therapy center
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Others
13.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Proton Therapy Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.6. Market Revenue and Forecast, by End-User (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.8.1. Market Revenue and Forecast, by End-User (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.10. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.11. Market Revenue and Forecast, by End-User (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.6. Market Revenue and Forecast, by End-User (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.9. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.10. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.10.1. Market Revenue and Forecast, by End-User (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.12. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.13. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.14. Market Revenue and Forecast, by End-User (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.15.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.16. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.16.1. Market Revenue and Forecast, by End-User (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.17.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.18. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.18.1. Market Revenue and Forecast, by End-User (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.6. Market Revenue and Forecast, by End-User (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.9. Market Revenue and Forecast, by End-User (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.11. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.11.1. Market Revenue and Forecast, by End-User (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.12.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.12.6. Market Revenue and Forecast, by End-User (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.13.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.13.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.9. Market Revenue and Forecast, by End-User (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.11. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.12. Market Revenue and Forecast, by End-User (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.13.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.13.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.14.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.14.6. Market Revenue and Forecast, by End-User (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.6. Market Revenue and Forecast, by End-User (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.8.1. Market Revenue and Forecast, by End-User (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.9.6. Market Revenue and Forecast, by End-User (2017-2030)
Chapter 15. Company Profiles
15.1. IBA Worldwide
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Varian medical systems, Inc
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. HItachi, Ltd
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Mevion medical systems
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Sumitomo Heavy Industries, Ltd
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Optivus Proton Therapy
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Advanced Oncotherapy plc
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. ProTom International
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Mitsubishi Corporation
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. ProNova Solutions LLC
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments